Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand
Authors:
- 1 November 2009
- journal article
- Published by Elsevier in NeuroImage
- Vol. 48 (2) , 362-370
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- PET Imaging of cannabinoid CB1 type receptors in healthy humans and patients with schizophrenia using [11C]OMARNeuroImage, 2008
- Synthesis, Ex Vivo Evaluation, and Radiolabeling of Potent 1,5-Diphenylpyrrolidin-2-one Cannabinoid Subtype-1 Receptor Ligands as Candidates for In Vivo ImagingJournal of Medicinal Chemistry, 2008
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in SchizophreniaArchives of General Psychiatry, 2008
- Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodentsNeuroImage, 2008
- Consensus Nomenclature for in vivo Imaging of Reversibly Binding RadioligandsJournal of Cerebral Blood Flow & Metabolism, 2007
- [18F]MK-9470, a positron emission tomography (PET) tracer forin vivohuman PET brain imaging of the cannabinoid-1 receptorProceedings of the National Academy of Sciences, 2007
- PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in ratNeuroscience Letters, 2007
- International Union of Pharmacology. XXVII. Classification of Cannabinoid ReceptorsPharmacological Reviews, 2002
- Effects of Temporal Sampling, Glucose Metabolic Rates, and Disruptions of the Blood—Brain Barrier on the FDG Model with and without a Vascular Compartment: Studies in Human Brain Tumors with PETJournal of Cerebral Blood Flow & Metabolism, 1986
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974